Subscribe
A worldwide window to Cambridge business, innovation and technology
Stem cell coup as Sanger and friends solve 50-year transplant mystery

Stem cell coup as Sanger and friends solve 50-year transplant mystery

Cambridge scientists have led a European project solving a medical mystery that has eluded researchers for more than half a century and paving the way for more successful transplants.
Kao Data chief wants UK-wide strategy to boost AI and compute sustainably

Kao Data chief wants UK-wide strategy to boost AI and compute sustainably

Kao Data, a UK-based developer of data centres engineered for AI, is seeking government involvement in the development of a UK wide data centre plan as part of a national strategy to bring the benefits of AI to the nation, without choking the planet with unsustainable practices.
Cambridge life science & technology company deals hit $22.5bn in 12 months

Cambridge life science & technology company deals hit $22.5bn in 12 months

Cambridge life science and technology companies have been involved in a dizzying series of acquisitions and fundraisings collectively worth more than $22.558 billion in the last 12 months (to October 16, 2024).
Epitopea raises US$31 million in pre-Series A financing round

Epitopea raises US$31 million in pre-Series A financing round

Transatlantic cancer immunotherapeutics company, Epitopea, has closed a US$31 million pre-Series A financing round.
‘Double vision’ as Cambridge unveils blueprint to fast-track innovation

‘Double vision’ as Cambridge unveils blueprint to fast-track innovation

A blurring vision to create the same level of innovation in the next 10 years as achieved in the whole last quarter-century promises to propel Cambridge and its hinterland to the peak of global technology transformation.
Academia
Sharewatch
Manufacturing
Stem cell coup as Sanger and friends solve 50-year transplant mystery
01 Nov 2024 - 12:00
Help shape the future of Cambridge workforce & skills base at gamechanging showcase
25 Oct 2024 - 12:00
Cambridge small island scholarships fit for the King
25 Oct 2024 - 12:00

Business awards

Entries now being accepted

Business directory

Browse our listings of Cambridge companies

The killer 50

The 50 hottest disruptive technology companies

News

Innovate Cambridge and Railpen open facility for scale-ups

Innovate Cambridge and Railpen open facility for scale-ups

Railpen, manager of the £34 billion railways pension schemes in the UK, and a key investor in Cambridge, has opened a 3,300 sq ft state-of-the-art innovation hub, named the Glasshouse, in partnership with Innovate Cambridge.
Poppy blooms in the land of the tulip

Poppy blooms in the land of the tulip

Former Darktrace CEO and now Minister for Investment, Poppy Gustafsson was in the Netherlands this week attending the annual World Pension Summit, with this year’s theme focusing on ‘Empowerment’.
SolasCure gel vetted by US military to combat war wounds

SolasCure gel vetted by US military to combat war wounds

A Cambridge-Texas collaboration may be used to bring relief to soldiers injured in battle. SolasCure’s investigational product, Aurase Wound Gel, is being tested by the U.S. Army Institute of Surgical Research (USAISR) in Houston as a means for managing combat wounds.
Cabinet backs plans to double Council Tax on second and empty properties in South Cambs

Cabinet backs plans to double Council Tax on second and empty properties in South Cambs

Plans to bring more empty homes in South Cambridgeshire back into use by doubling council tax on long-term vacant or second properties are very much alive.
More news

Tech trail

Plotting the inevitable rise of quantum computing

Plotting the inevitable rise of quantum computing

Almost every day, it seems like there is another article about how quantum computing is poised to revolutionise the world, and our place in it.
Shift Bioscience raises $16m seed cash to fast-track AI anti-ageing research

Shift Bioscience raises $16m seed cash to fast-track AI anti-ageing research

Shift Bioscience, a Cambridge biotech using generative AI models to understand how activation of different genes can reverse the ageing process, has raised $16 million seed cash. BGF lead the round, with existing investors F-Prime Capital, Kindred Capital and Abcam co-founder and serial investor Jonathan Milner participating.
Neutreeno poised to clean up in $130 Trillion decarbonisation market

Neutreeno poised to clean up in $130 Trillion decarbonisation market

Neutreeno, a pioneering DeepTech startup spinning out of the University of Cambridge, has secured $5 million seed cash from a global syndicate of mission-aligned investors to target a $130 trillion decarbonisation market.
Timely $5.3 million helps clock.bio boost rejuvenation roadmap

Timely $5.3 million helps clock.bio boost rejuvenation roadmap

Cambridge-based clock.bio, a healthspan biotech working to reverse ageing, has raised $5.3 million seed funding led by LocalGlobe, with participation from BlueYard Capital, Onsight Ventures and serial Cambridge life science entrepreneur Dr Jonathan Milner.
More Tech trail

Trade floor

ML from Intellegens to revolutionise steel industry

ML from Intellegens to revolutionise steel industry

Cambridge based machine learning specialist Intellegens is collaborating with the UK’s Materials Processing Institute (MPI) to reduce carbon emissions from the next generation of Electric Arc Furnaces (EAFs).
Xampla and Quadram Institute funded to progress gut health initiative

Xampla and Quadram Institute funded to progress gut health initiative

Cambridge-based materials innovation company Xampla and the Quadram Institute in Norwich have been awarded unspecified Innovate UK and BBSRC grant funding to advance probiotic microencapsulation technology.
ViaNautis signs multi-year collaboration with Eli Lilly and Company

ViaNautis signs multi-year collaboration with Eli Lilly and Company

ViaNautis Bio in Cambridge has signed a strategic collaboration agreement with Eli Lilly and Company to leverage its polyNaut® platform to develop novel products delivering genetic medicines.
Acquisitions: US billions secures ownership of Cambridge life science and technology companies

Acquisitions: US billions secures ownership of Cambridge life science and technology companies

The last 12 months (to October 16, 2024) has seen the sale of a number of Cambridge’s life science and technology companies, the majority into US hands. The two biggest acquisitions saw Abcam bought by Danaher for $5.7 billion last December and Darktrace taken by Thoma Bravo for $5.3bn – a deal that completed on October 1.
ICE and fire alliance for Cambridge UK-China techbio

ICE and fire alliance for Cambridge UK-China techbio

A techbio partnership between Cambridge and China has led to the creation of a new joint laboratory as well as hopes for fresh bridges to be built between the territories.
More Trade floor